Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection.

20 patients with cervicocephalic arterial dissection will be randomized to open-label aspirin or warfarin, rate of stroke and adverse events will be endpoints.

Inclusion Criteria:

• Clinical and imaging diagnosis of cervicocephalic arterial dissection within 3 months.

Exclusion Criteria:

• Any contraindication to aspirin or warfarin.